Skip to main content
Basilea Pharmaceutica AG (SWX:BSLN)
Switzerland flag Switzerland · Delayed Price · Currency is CHF
51.60
+0.40 (0.78%)
At close: Dec 5, 2025

Basilea Pharmaceutica AG Revenue

Basilea Pharmaceutica AG had revenue of 103.96M CHF in the half year ending June 30, 2025, with 22.44% growth. This brings the company's revenue in the last twelve months to 236.21M, up 58.51% year-over-year. In the year 2024, Basilea Pharmaceutica AG had annual revenue of 208.54M with 32.30% growth.

Revenue (ttm)
236.21M
Revenue Growth
+58.51%
P/S Ratio
2.68
Revenue / Employee
1.31M
Employees
164
Market Cap
634.04M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2024208.54M50.91M32.30%
Dec 31, 2023157.63M9.87M6.68%
Dec 31, 2022147.77M-357.00K-0.24%
Dec 31, 2021148.12M20.49M16.06%
Dec 31, 2020127.63M-6.75M-5.02%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Roche Holding AG 63.49B
Novartis AG 44.95B
Galderma Group AG 3.73B
Lonza Group AG 7.09B
Alcon 8.12B
Sandoz Group AG 8.42B
Straumann Holding AG 2.58B
Sonova Holding AG 3.85B
Revenue Rankings

Basilea Pharmaceutica AG News

More News